We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Tile-Based Radiation Therapy Reduces Recurrence Risk After Brain Metastasis Surgery

By HospiMedica International staff writers
Posted on 01 Oct 2026

Brain metastases can occur in patients with advanced solid tumors and may affect treatment options and prognosis. More...

For patients with larger or symptomatic lesions requiring surgery, microscopic tumor cells left in the surgical cavity can cause recurrence in 50%–60% of cases without radiation. Standard postoperative stereotactic radiation therapy must be delivered on schedule, but delays and missed treatment can compromise care. New findings demonstrate that tile-based radiation therapy may improve local tumor control after surgery.

Researchers at the University of Texas MD Anderson Cancer Center led the multicenter ROADS trial evaluating GammaTile cesium-131 collagen tile-based radiation therapy, or TBRT. The approach uses a Food and Drug Administration (FDA)-cleared low-dose brachytherapy device developed by GT Medical Technologies Inc. The postage-stamp-sized collagen tiles contain evenly spaced cesium-131 seeds and are placed along the surgical cavity during brain surgery.

The tiles deliver low-dose therapeutic radiation over several weeks to the cavity surface, where remaining microscopic tumor cells are most likely to be located. The source material states that brachytherapy has rapid dose fall-off, limiting radiation exposure to healthy brain tissue. The ROADS trial compared surgery plus TBRT with surgery plus standard postoperative stereotactic radiation therapy, or SRT, in patients with newly diagnosed brain metastases who needed surgery.

ROADS was the first randomized controlled Phase III trial comparing GammaTile TBRT with standard-of-care postoperative SRT. After one year, recurrence at the surgical site was 1.3% in the TBRT group compared with 15.4% in the SRT group. Median overall survival was 42.5 months with TBRT and 17.6 months with standard SRT, a key secondary endpoint of the trial.

Serious treatment-related side effects did not differ between the two groups. Radiation necrosis rates were nearly identical. Patients receiving TBRT completed cranial radiation faster, most in one day, compared with a median of 32 days for patients who needed postoperative SRT.

The study was published in the Journal of Clinical Oncology on September 28, 2026, and presented at the 2026 American Society of Clinical Oncology Annual Meeting. The investigators stated that the results could reduce logistical challenges associated with SRT and improve disease control in the brain. Future work may evaluate how broadly TBRT affects metastasis care and whether it has potential in other tumor types.

“Implanting the radioactive tiles at the time of surgery guarantees that patients receive their treatment immediately, along with focal dose escalation, thereby having meaningful impact on local tumor control. From a patient standpoint, we're showing that there's almost four times the length of local control and an increase in overall survival. It's not just a little difference. It's a massive difference,” said Jeffrey Weinberg, M.D., professor of neurosurgery.

Related Links
GT Medical Technologies 
UT MD Anderson Cancer Center


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Adhesive
MED 5570U
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
From left: Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel Ode, Head of Ericsson Singapore, Brunei and Philippines and Global Customer Unit Singtel, signed a Memorandum of Understanding to advance connected healthcare, 5G-Advanced and 6G technology, as well as connected intelligence. (Photo courtesy of National University Health System)

Healthcare Partnership Creates Testbed for Advanced Connectivity and AI Applications

Hospitals face growing care complexity, aging populations, and pressure to extend monitoring beyond traditional inpatient settings. Meeting these demands requires more responsive clinical workflows and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.